The book contains 17 chapters categorized into 3 sections. The first section presents the latest information on bioinformatics tools, artificial intelligence, machine learning, computational methods, protein interactions, peptide-based drug design and omics technologies. The following 2 sections include bioinformatics tools for the pharmaceutical sector and for the healthcare sector. Bioinformatics brings a new era in research with the aim to accelerate drug target and vaccine design development, improve validation approaches as well as facilitate in identifying side effects and predict drug resistance. As such, this will aid in more successful drug candidates from discovery to clinical trials to the market, and most importantly making it a more cost-effective process overall.
The book contains 17 chapters categorized into 3 sections. The first section presents the latest information on bioinformatics tools, artificial intelligence, machine learning, computational methods, protein interactions, peptide-based drug design and omics technologies. The following 2 sections include bioinformatics tools for the pharmaceutical sector and for the healthcare sector. Bioinformatics brings a new era in research with the aim to accelerate drug target and vaccine design development, improve validation approaches as well as facilitate in identifying side effects and predict drug resistance. As such, this will aid in more successful drug candidates from discovery to clinical trials to the market, and most importantly making it a more cost-effective process overall.
Sprache
Verlagsort
Zielgruppe
Maße
Höhe: 229 mm
Breite: 152 mm
Dicke: 25 mm
Gewicht
ISBN-13
978-1-119-86511-7 (9781119865117)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Klassifikation
The editors are well-known experts in their respective fields of bioinformatics, computational chemistry, drug discovery, vaccines, nanotechnology and chronic disease management. Editors Dr. Vivek Chavda, Dr. Krishnan Anand and Dr. Vasso Apostolopoulos have several publications in the field of chronic diseases, vaccines, pharmaceutical drug product development, bioinformatics, drug design, and drug delivery systems.
The editors are well-known experts in their respective fields of bioinformatics, computational chemistry, drug discovery, vaccines, nanotechnology and chronic disease management. Editors Dr. Vivek Chavda, Dr. Krishnan Anand and Dr. Vasso Apostolopoulos have several publications in the field of chronic diseases, vaccines, pharmaceutical drug product development, bioinformatics, drug design, and drug delivery systems.
